Skip to main content
Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0530
+0.0005 (0.99%)
At close: Mar 6, 2026

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $350.44K in the twelve months ending September 30, 2025, down -51.59% year-over-year. In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth.

Revenue (ttm)
350.44K
Revenue Growth
-51.59%
P/S Ratio
63.59
Revenue / Employee
58.41K
Employees
6
Market Cap
22.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024617.14K59.43K10.66%
Dec 31, 2023557.71K-431.33K-43.61%
Dec 31, 2022989.04K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Apparatus Regenerative Technology 743.00K
Zeo ScientifiX 5.20M
HOOKIPA Pharma 9.35M
ZIVO Bioscience 209.03K
Zenith Capital 500.00K
Arch Biopartners 115.29K
Revenue Rankings

Provectus Biopharmaceuticals News

More News